Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.9750
-0.0550 (-2.71%)
NASDAQ· Last Trade: Jul 1st, 1:32 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors